Trial intelligence / Profile preview

Dexmedetomidine vs Midazolam for Postoperative Delirium in CABG

NCT07411794Completed

Sponsor
Sivas Cumhuriyet University
Start
Jan 2026
Primary completion
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in postoperative delirium (POD) comparing Dexmedetomidine with Midazolam (2 arms). Primary endpoint: Incidence of Postoperative Delirium at 24 hours. Started Jan 2026; status: completed.

02

Drugs

dexmedetomidinemidazolam
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT07411794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07411794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call